Skip to main content
. 2021 Jan 25;21:40. doi: 10.1186/s12890-021-01394-w

Table 2.

Baseline characteristics and outcome of patients with moderate to severe acute respiratory distress syndrome in this study

Characteristics Non-CRRT (n = 33) CRRT (n = 37) P value
Age, month 24 (9–53) 35 (12–52) 0.667
Male, n (%) 19 (57.58) 22 (59.46) 0.873
PRISM III 15 (12–18) 17 (15–20) 0.016
BMI, kg/m (2) 14.70 (12.65–16.86) 14.00 (12.70–16.38) 0.778
Co-morbidity, n (%)
 Immune system disease 1 (3.03) 4 (10.81) 0.207
 Genetic metabolic disease 1 (3.03) 0 (0) 0.286
 Leukemia/tumor 6 (18.18) 7 (18.92) 0.937
Complication, n (%)
 Hepatic failure 2 (6.06) 1 (2.70) 0.489
 AKI 9 (27.27) 25 (67.57) 0.001
 Brain dysfunction 1 (3.03) 1 (2.70) 0.935
 Gastrointestinal dysfunction 2 (6.06) 3 (8.11) 0.740
 Pancreatitis 0 (0) 2 (5.41) 0.175
OI 7.69 (6.46–9.50) 13.15 (10.00–14.78) < 0.001
PaCO2, mmHg 55.00 (38.00–61.00) 45.00 (34.50–62.00) 0.225
Mechanical ventilation settings
 PIP, cmH2O 26 (25–28) 29 (27–31) < 0.001
 PEEP, cmH2O 9 (8–10) 12 (11–14) < 0.001
 FiO2 0.55 (0.50–0.74) 0.70 (0.60–0.88) 0.002
Duration of mechanical ventilation, day 6 (4–9) 8 (6–15) 0.012
Length of PICU stay, day 10 (6–17) 14 (10–20) 0.047
Length of hospital stay, day 19 (12–30) 24 (17–35) 0.081
Hospital mortality, n (%) 11 (33.33) 16 (43.24) 0.395